These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24698468)

  • 1. Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes).
    Manfrini O; Morrell C; Das R; Barth JH; Hall AS; Gale CP; Cenko E; Bugiardini R;
    Am J Cardiol; 2014 May; 113(10):1628-33. PubMed ID: 24698468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with acute coronary syndrome and nonobstructive coronary artery disease in the real world are markedly undertreated.
    De Ferrari GM; Leonardi S; Baduena L; Chieffo E; Lesce A; Repetto A; Previtali M
    J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):700-8. PubMed ID: 21738050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of cardiac medications upon discharge among men and women with acute coronary syndrome and nonobstructive coronary artery disease.
    Ramanath VS; Armstrong DF; Grzybowski M; Rahnama-Mohagdam S; Tamhane UU; Gordon K; Froehlich JB; Eagle KA; Jackson EA
    Clin Cardiol; 2010 Jan; 33(1):36-41. PubMed ID: 20063300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes.
    Singh SM; Goodman SG; Yan RT; Dery JP; Wong GC; Gallo R; Grondin FR; Lai K; Lopez-Sendon J; Fox KA; Yan AT;
    Am J Cardiol; 2012 Feb; 109(3):332-6. PubMed ID: 22078966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease.
    Ndrepepa G; Braun S; Schömig A; Kastrati A
    Clin Res Cardiol; 2011 Apr; 100(4):327-33. PubMed ID: 21053005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute coronary syndromes in patients with active hematologic malignancies - Incidence, management, and outcomes.
    Park JY; Guo W; Al-Hijji M; El Sabbagh A; Begna KH; Habermann TM; Witzig TE; Lewis BR; Lerman A; Herrmann J
    Int J Cardiol; 2019 Jan; 275():6-12. PubMed ID: 30318297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of evidence-based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry.
    Al-Zakwani I; Zubaid M; Alsheikh-Ali AA; Almahmeed W; Rashed W
    Cardiovasc Ther; 2018 Dec; 36(6):e12463. PubMed ID: 30079461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-associated AKI and use of cardiovascular medications after acute coronary syndrome.
    Leung KC; Pannu N; Tan Z; Ghali WA; Knudtson ML; Hemmelgarn BR; Tonelli M; James MT;
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1840-8. PubMed ID: 25318754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiac medications for patients with obstructive coronary artery disease by coronary computed tomographic angiography: results from the multicenter CONFIRM registry.
    Schulman-Marcus J; Hartaigh BÓ; Giambrone AE; Gransar H; Valenti V; Berman DS; Budoff MJ; Achenbach S; Al-Mallah M; Andreini D; Cademartiri F; Callister TQ; Chang HJ; Chinnaiyan K; Chow BJ; Cury R; Delago A; Hadamitzky M; Hausleiter J; Feuchtner G; Kim YJ; Kaufmann PA; Leipsic J; Lin FY; Maffei E; Pontone G; Raff G; Shaw LJ; Villines TC; Dunning A; Min JK
    Atherosclerosis; 2015 Jan; 238(1):119-25. PubMed ID: 25479800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.
    Mentz RJ; Allen BD; Kwasny MJ; Konstam MA; Udelson JE; Ambrosy AP; Fought AJ; Vaduganathan M; O'Connor CM; Zannad F; Maggioni AP; Swedberg K; Bonow RO; Gheorghiade M
    Eur J Heart Fail; 2013 Jan; 15(1):61-8. PubMed ID: 22968743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins.
    Enriquez JR; Pratap P; Zbilut JP; Calvin JE; Volgman AS
    Gend Med; 2008 Mar; 5(1):53-61. PubMed ID: 18420166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.